ResMed Inc. (RMD): Price and Financial Metrics


ResMed Inc. (RMD)

Today's Latest Price: $221.32 USD

5.80 (2.69%)

Updated Jan 25 3:27pm

Add RMD to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 186 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

RMD Stock Summary

  • Resmed Inc's market capitalization of $31,232,113,775 is ahead of 92.36% of US-listed equities.
  • Price to trailing twelve month operating cash flow for RMD is currently 39.84, higher than 87.89% of US stocks with positive operating cash flow.
  • With a price/sales ratio of 10.31, Resmed Inc has a higher such ratio than 83.03% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Resmed Inc are A, CSGP, CERN, EBAY, and BAX.
  • Visit RMD's SEC page to see the company's official filings. To visit the company's web site, go to www.resmed.com.

RMD Stock Price Chart Interactive Chart >

Price chart for RMD

RMD Price/Volume Stats

Current price $221.32 52-week high $224.24
Prev. close $215.52 52-week low $108.85
Day low $215.73 Volume 330,850
Day high $224.00 Avg. volume 430,662
50-day MA $212.44 Dividend yield 0.72%
200-day MA $186.07 Market Cap 32.07B

ResMed Inc. (RMD) Company Bio


ResMed Inc. develops, manufactures, distributes, and markets medical equipment for the diagnosis, treatment, and management of respiratory disorders with a focus on sleep-disordered breathing. The company was founded in 1989 and is based in San Diego, California.

RMD Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$221.32$67.43 -69%

Below please find a table outlining a discounted cash flow forecast for RMD, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Resmed Inc ranked in the 26th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 68.5%. The most interesting components of our discounted cash flow analysis for Resmed Inc ended up being:

  • The company's debt burden, as measured by earnings divided by interest payments, is 23.04; that's higher than 86.26% of US stocks in the Healthcare sector that have positive free cash flow.
  • The business' balance sheet reveals debt to be 4% of the company's capital (with equity being the remaining amount). Approximately just 14.38% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
  • RMD's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 45.55% of tickers in our DCF set.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-69%
1%-69%
2%-69%
3%-68%
4%-68%
5%-68%

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as RMD, try ABT, AZN, ABC, CPIX, and HSIC.


RMD Latest News Stream


Event/Time News Detail
Loading, please wait...

RMD Latest Social Stream


Loading social stream, please wait...

View Full RMD Social Stream

Latest RMD News From Around the Web

Below are the latest news stories about Resmed Inc that investors may wish to consider to help them evaluate RMD as an investment opportunity.

Year 2020 was for Ventilator Manufacturers, Know about year 2021 | Key Players: ResMed, Philips Healthcare, Medtronic, Getinge, Becton, Dickinson and Company, Drager, Nihon Kohden

Mechanical ventilation, forced air, or intermittent forced ventilation are the technical terms for mechanical ventilation in which mechanical means are employed to help replace or aid breathing in specific situations. As a medical terminology, mechanical ventilation is used to refer

OpenPR | January 21, 2021

ResMed(RMD) Presents At 39th Annual J.P. Morgan Healthcare Conference - Slideshow

The following slide deck was published by ResMed Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | January 20, 2021

Non-invasive Ventilators Market – Global Industry Analysis, Trends, Production, Revenue, Gross Margin Analysis and Forecast 2020-2026|Key Top Players- Philips Healthcare, ResMed, Medtronic, Becton, Dickinson, Getinge, Dräger, Smiths Group, Hamilton Med

ReportsnReports.com the exclusive leading provider of market research reports published research report on “Global Non-invasive Ventilators Market Research Report 2020”. The Global Non-invasive Ventilators Market Report is a professional and in-depth study on the current state of the Non-invasive Ventilators Market. The

OpenPR | January 20, 2021

Is ResMed Inc. (NYSE:RMD) Popular Amongst Institutions?

Every investor in ResMed Inc. ( NYSE:RMD ) should be aware of the most powerful shareholder groups. Large companies...

Yahoo | January 18, 2021

ResMed Inc. (NYSE:RMD) CFO Brett Sandercock Sells 2,500 Shares of Stock

ResMed Inc. (NYSE:RMD) CFO Brett Sandercock sold 2,500 shares of the firm’s stock in a transaction dated Monday, January 11th. The shares were sold at an average price of $218.70, for a total value of $546,750.00. Following the sale, the chief financial officer now owns 100,600 shares of the company’s stock, valued at $22,001,220. The […]

Watchlist News | January 13, 2021

Read More 'RMD' Stories Here

RMD Price Returns

1-mo N/A
3-mo 19.94%
6-mo 8.86%
1-year 37.45%
3-year 123.07%
5-year 314.38%
YTD 4.12%
2020 38.33%
2019 37.85%
2018 36.38%
2017 39.06%
2016 18.01%

RMD Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full RMD Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8212 seconds.